Dublin, Aug. 19, 2024 (GLOBE NEWSWIRE) -- The "Epinephrine Auto-Injection Market - Focused Insights 2024-2029" report has been added to ResearchAndMarkets.com's offering. The Epinephrine ...

Allergists Dr Andrew Clark and Dr Shuaib Nasser offer tips on who needs one and advice to give patients 1. Any patient who has experienced symptoms of airway narrowing or cardiovascular compromise ...

UK medicines regulators have approved an adrenaline nasal spray to treat anaphylaxis. The needle-free option can be used in adults and children weighing over 30kg, the Medicines and Healthcare ...

Recurrence of anaphylaxis can occur a long time after the adrenaline auto-injector (AAI) is first prescribed. It is therefore important that the person who has received treatment for anaphylaxis, or ...

MHRA has issued a drug alert for the Emerade adrenaline auto-injector device, as a result of the device’s potential to fail in delivery of the dose due to blockage of the needle. The Medicines and ...

Sanofi has launched a voice-guided epinephrine auto-injector Auvi-Q in the US to provide emergency treatment for life-threatening allergic reactions in people who are at risk for, or have a history of ...

Walgreens, a drugstore chains and Kaléo, a privately-held pharmaceutical company, announced AUVI-q (epinephrine injection, USP) 0.1 mg auto-injector is available at Walgreens locations nationwide.

Retrospective Analysis of U.S. Claims Data Shows AUVI-Q® (epinephrine injection, USP) Prescription Associated with Lower Rates of Anaphylaxis-Related Inpatient Hospitalizations Compared to Other ...

ALLERGY sufferers are being urged to check their adrenaline pens after health bosses warned there may be a fault with a batch of injectors. Health bosses say there is a risk of some Emerade pens ...

Richmond, Virginia, May 15, 2025 (GLOBE NEWSWIRE) -- New findings from a retrospective analysis of U.S. commercial claims data indicate that patients prescribed AUVI-Q ® (epinephrine injection, USP) ...